Skip to content
PubMed This is a summary of 38 peer-reviewed journal articles Updated
Medical Genetics · Clouston Syndrome

Understanding Clouston Syndrome (Hidrotic Ectodermal Dysplasia)

At a Glance

Clouston Syndrome (hidrotic ectodermal dysplasia) is a rare genetic condition causing hair loss, abnormal nails, and thickened skin on the hands and feet. Unlike other forms of ectodermal dysplasia, patients have normal teeth, normal sweating, and a normal life expectancy.

If you have recently been diagnosed with Clouston Syndrome (also known as Hidrotic Ectodermal Dysplasia), it is natural to feel overwhelmed. This is an extremely rare genetic condition, affecting only about 1 out of every 660,000 people (or 0.15 in 100,000) [1]. Because it is so rare, you may find that many general healthcare providers have never encountered it before [2][3].

A Crucial Warning About Googling: In medical literature and patient advocacy, the acronym HED is almost always used for a completely different condition called Hypohidrotic Ectodermal Dysplasia. If you search for “HED” online, you will find terrifying information about life-threatening overheating and missing teeth. This does not apply to you.

The most important thing to understand immediately is the word hidrotic (from the Greek word for “sweat”). While many other forms of ectodermal dysplasia are “hypohidrotic” (meaning the person cannot sweat and may overheat dangerously), people with Clouston Syndrome have normal sweat gland function [4][5].

The Three Hallmarks: Hair, Nails, and Skin

Clouston Syndrome primarily affects the tissues derived from the ectoderm, which is the outermost layer of a developing embryo [6]. This results in a “classic triad” of physical features that usually appear in early childhood and tend to persist throughout life (though hair loss may progressively worsen with age):

  1. Hair Abnormalities (Alopecia): This may include very thin, sparse, or brittle hair on the scalp, eyebrows, and eyelashes. In some cases, it can lead to total hair loss [7][3].
  2. Nail Dystrophy: The nails on the fingers and toes are often the first sign of the condition. They may be thickened, discolored, slow-growing, or unusually brittle [7][8].
  3. Skin Thickening (Palmoplantar Keratoderma): This is a thickening of the skin on the palms of the hands and the soles of the feet. This skin can become quite hard and, in some cases, painful or prone to infection [7][3].

Why Clouston Syndrome is Different

It is common for patients to be confused with other types of Ectodermal Dysplasia. Here is how Clouston Syndrome is distinct:

  • Normal Sweating: You do not have the heat intolerance or life-threatening overheating issues seen in the more common hypohidrotic types [9][6].
  • Healthy Teeth: Unlike other forms where teeth may be missing or pointed, people with Clouston Syndrome typically have normal dental development [10].
  • Genetic Cause: The condition is usually caused by a mutation in the GJB6 gene, which provides instructions for making a protein called connexin 30 [11]. This protein helps cells communicate. When the gene is mutated, it creates “leaky” channels in the cells that disrupt the normal development of the skin and hair [12][13].

What You Need to Know Now

  • It is Autosomal Dominant: This means you only need one copy of the changed gene to have the condition. There is a 50% chance of passing the condition on to each child [4][7]. However, the mutation can also happen spontaneously (de novo) in a child with no family history of the disorder.
  • Management is Supportive: While there is currently no “cure” that changes the genetic code, the symptoms can be managed. This often involves using keratolytics (skin-softening agents like urea or salicylic acid) for the skin on the feet and seeking dermatological care for hair and nail health [14][3].
  • Life Expectancy is Normal: Clouston Syndrome does not typically affect internal organs or the immune system. With proper skin and foot care, most individuals live full, healthy lives [7][15].

Common Overlaps and Differences

Feature Clouston Syndrome (Hidrotic) Hypohidrotic ED (HED/CST)
Sweating Normal [4] Reduced or Absent [9]
Teeth Normal [10] Missing or Pointed [16]
Nails Thickened/Dystrophic [7] Often Normal
Skin Thick palms/soles [3] Thin, dry skin
Inheritance Autosomal Dominant [4] Often X-linked Recessive [17]

Further Reading

Common questions in this guide

Is Clouston Syndrome the same as HED?
No. While sometimes called hidrotic ectodermal dysplasia, Clouston Syndrome is different from hypohidrotic ectodermal dysplasia (often abbreviated online as HED). People with Clouston Syndrome have normal sweat glands, healthy teeth, and do not experience dangerous overheating.
What are the main symptoms of Clouston Syndrome?
The condition is known for a classic triad of symptoms: thinning or complete loss of hair (alopecia), thickened or brittle nails, and hard, thickened skin on the palms of the hands and soles of the feet (palmoplantar keratoderma).
What causes hidrotic ectodermal dysplasia?
The condition is usually caused by an inherited mutation in the GJB6 gene, which affects a protein called connexin 30. This mutation disrupts normal cell communication, leading to the abnormal development of the hair, skin, and nails.
How is Clouston Syndrome treated?
While there is no genetic cure, symptoms are managed through supportive care. This often includes using skin-softening creams called keratolytics for the hands and feet, alongside regular visits to a dermatologist and podiatrist.
What is the life expectancy for someone with Clouston Syndrome?
People with Clouston Syndrome typically have a normal life expectancy. The condition primarily affects the skin, hair, and nails, and does not involve internal organs or the immune system.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my specific genetic mutation (e.g., in the GJB6 gene) tell us anything about how my symptoms might progress?
  2. 2.Can you refer me to a dermatologist who has experience managing palmoplantar keratoderma in rare genetic conditions?
  3. 3.What topical treatments or 'keratolytics' do you recommend to manage the thickening of my skin on my palms and soles?
  4. 4.Is there a specific podiatrist you recommend for managing nail dystrophy and foot care?
  5. 5.Are there any local or national patient support groups specifically for Ectodermal Dysplasias that you suggest joining?
  6. 6.Since this condition is inherited in an 'autosomal dominant' way, what are the risks for my children, and should they be tested?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Novel clinical features associated with Clouston syndrome.

    Cammarata-Scalisi F, Rinelli M, Pisaneschi E, et al.

    International journal of dermatology 2019; (58(8)):e143-e146 doi:10.1111/ijd.14507.

    PMID: 31165482
  2. 2

    Immune system disturbances in Clouston syndrome.

    Pietrzak A, Grywalska E, Gerkowicz A, et al.

    International journal of dermatology 2016; (55(5)):e241-9 doi:10.1111/ijd.13152.

    PMID: 26551294
  3. 3

    Clouston Syndrome: Report of a Jordanian Family with GJB6 Gene Mutation.

    Murshidi R, Al-Lala H

    Case reports in dermatological medicine 2023; (2023()):5577379 doi:10.1155/2023/5577379.

    PMID: 37869104
  4. 4

    A known mutation in GJB6 in a large Chinese family with hidrotic ectodermal dysplasia.

    Yang R, Hu Z, Kong Q, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2016; (30(8)):1362-5 doi:10.1111/jdv.13600.

    PMID: 27137747
  5. 5

    Characterization of a novel gross deletion and insertion mutation in EDA gene causing hypohidrotic ectodermal dysplasia.

    Sun J, Chen L, Han S, et al.

    The Journal of dermatology 2021; (48(1)):e29-e30 doi:10.1111/1346-8138.15653.

    PMID: 33180991
  6. 6

    Reproductive decision-making by women with X-linked hypohidrotic ectodermal dysplasia.

    Leo B, Schneider H, Hammersen J

    Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(10)):1863-1870 doi:10.1111/jdv.18267.

    PMID: 35611639
  7. 7

    Do you know this syndrome? Clouston syndrome.

    Sanches S, Rebellato PRO, Fabre AB, Campos GLM

    Anais brasileiros de dermatologia 2017; (92(3)):417-418 doi:10.1590/abd1806-4841.20175716.

    PMID: 29186264
  8. 8

    Diffuse Palmoplantar Keratoderma, Onychodystrophy, universal Hypotrichosis and Cysts.

    Arif T, Amin SS, Adil M, Mohtashim M

    Acta dermatovenerologica Croatica : ADC 2017; (25(2)):161-163.

    PMID: 28871934
  9. 9

    Clinical, radiographic, and genetic characteristics of hypohidrotic ectodermal dysplasia: A cross-sectional study.

    Ngoc VTN, Duong NT, Chu DT, et al.

    Clinical genetics 2018; (94(5)):484-486 doi:10.1111/cge.13435.

    PMID: 30192988
  10. 10

    Pterygium and thinning of nails as an unusual manifestation in Clouston syndrome.

    Sukakul T, Yang HS, Onoufriadis A, et al.

    The Journal of dermatology 2019; (46(9)):e329-e330 doi:10.1111/1346-8138.14867.

    PMID: 30908727
  11. 11

    [A gene study of a family with hidrotic ectodermal dysplasia].

    Qiao WX, Liu L

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2016; (18(11)):1141-1144.

    PMID: 27817781
  12. 12

    The genetic and molecular basis of a connexin-linked skin disease.

    Lucaciu SA, Laird DW

    The Biochemical journal 2024; (481(22)):1639-1655 doi:10.1042/BCJ20240374.

    PMID: 39513663
  13. 13

    From Hyperactive Connexin26 Hemichannels to Impairments in Epidermal Calcium Gradient and Permeability Barrier in the Keratitis-Ichthyosis-Deafness Syndrome.

    García IE, Bosen F, Mujica P, et al.

    The Journal of investigative dermatology 2016; (136(3)):574-583 doi:10.1016/j.jid.2015.11.017.

    PMID: 26777423
  14. 14

    Botanical extract combined with minoxidil improve hidrotic ectodermal dysplasia caused by p.G11R mutations: a case report.

    Zhong S, Huang C, Zhuang M, et al.

    The Journal of dermatological treatment 2024; (35(1)):2378163 doi:10.1080/09546634.2024.2378163.

    PMID: 38991555
  15. 15

    Clouston Syndrome: 25-year follow-up of a patient.

    Trídico LA, Antonio JR, Pozetti EM, et al.

    Anais brasileiros de dermatologia 2015; (90(6)):897-9.

    PMID: 26734875
  16. 16

    [Detection of EDA gene mutation and phenotypic analysis in patients with hypohidrotic ectodermal dysplasia].

    Wu JY, Yu M, Sun SC, et al.

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2020; (53(1)):24-33.

    PMID: 33550332
  17. 17

    Christ-Siemens-Touraine Syndrome: A Rare Case Report.

    Kumar A, Thomas P, Muthu T, Mathayoth M

    Journal of pharmacy & bioallied sciences 2019; (11(1)):102-104 doi:10.4103/jpbs.JPBS_36_18.

    PMID: 30906146

This page provides educational information about Clouston Syndrome and its symptoms. It is not a substitute for professional medical advice, diagnosis, or treatment from your dermatologist or geneticist.

Get notified when new evidence is published on Hidrotic ectodermal dysplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.